BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · IEX Real-Time Price · USD
87.16
-1.45 (-1.64%)
Mar 28, 2024, 1:43 PM EDT - Market open

Total Valuation

BMRN has a market cap or net worth of $16.72 billion. The enterprise value is $16.73 billion.

Market Cap 16.72B
Enterprise Value 16.73B

Important Dates

The next estimated earnings date is Wednesday, April 24, 2024, after market close.

Earnings Date Apr 24, 2024
Ex-Dividend Date n/a

Share Statistics

BMRN has 188.68 million shares outstanding. The number of shares has increased by 1.39% in one year.

Shares Outstanding 188.68M
Shares Change (YoY) +1.39%
Shares Change (QoQ) -5.19%
Owned by Insiders (%) 0.68%
Owned by Institutions (%) 101.51%
Float 187.26M

Valuation Ratios

The trailing PE ratio is 101.38 and the forward PE ratio is 52.93. BMRN's PEG ratio is 0.73.

PE Ratio 101.38
Forward PE 52.93
PS Ratio 6.91
Forward PS 5.96
PB Ratio 3.38
P/FCF Ratio 267.21
PEG Ratio 0.73
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 53.92, with an EV/FCF ratio of 267.42.

EV / Earnings 99.80
EV / Sales 6.92
EV / EBITDA 53.92
EV / EBIT 81.26
EV / FCF 267.42

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.22.

Current Ratio 2.51
Quick Ratio 1.45
Debt / Equity 0.22
Debt / EBITDA 3.50
Debt / FCF 17.37
Interest Coverage 11.88

Financial Efficiency

Return on equity (ROE) is 3.50% and return on invested capital (ROIC) is 2.33%.

Return on Equity (ROE) 3.50%
Return on Assets (ROA) 2.50%
Return on Capital (ROIC) 2.33%
Revenue Per Employee $711,328
Profits Per Employee $49,293
Employee Count 3,401
Asset Turnover 0.36
Inventory Turnover 0.51

Taxes

In the past 12 months, BMRN has paid $20.92 million in taxes.

Income Tax 20.92M
Effective Tax Rate 11.09%

Stock Price Statistics

The stock price has decreased by -3.16% in the last 52 weeks. The beta is 0.31, so BMRN's price volatility has been lower than the market average.

Beta (1Y) 0.31
52-Week Price Change -3.16%
50-Day Moving Average 88.22
200-Day Moving Average 89.30
Relative Strength Index (RSI) 58.19
Average Volume (30 Days) 1,325,206

Short Selling Information

The latest short interest is 2.96 million, so 1.57% of the outstanding shares have been sold short.

Short Interest 2.96M
Short Previous Month 3.06M
Short % of Shares Out 1.57%
Short % of Float 1.58%
Short Ratio (days to cover) 1.94

Income Statement

In the last 12 months, BMRN had revenue of $2.42 billion and earned $167.65 million in profits. Earnings per share was $0.87.

Revenue 2.42B
Gross Profit 1.90B
Operating Income 158.10M
Pretax Income 188.56M
Net Income 167.65M
EBITDA 310.28M
EBIT 205.90M
Earnings Per Share (EPS) $0.87
Full Income Statement

Balance Sheet

The company has $1.07 billion in cash and $1.09 billion in debt, giving a net cash position of -$13.16 million or -$0.07 per share.

Cash & Cash Equivalents 1.07B
Total Debt 1.09B
Net Cash -13.16M
Net Cash Per Share -$0.07
Equity / Book Value 4.95B
Book Value Per Share 26.24
Working Capital 1.78B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $159.26 million and capital expenditures -$96.69 million, giving a free cash flow of $62.57 million.

Operating Cash Flow 159.26M
Capital Expenditures -96.69M
Free Cash Flow 62.57M
FCF Per Share $0.33
Full Cash Flow Statement

Margins

Gross margin is 78.72%, with operating and profit margins of 6.54% and 6.93%.

Gross Margin 78.72%
Operating Margin 6.54%
Pretax Margin 7.79%
Profit Margin 6.93%
EBITDA Margin 12.83%
EBIT Margin 8.51%
FCF Margin 2.59%

Dividends & Yields

BMRN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.39%
Shareholder Yield -1.39%
Earnings Yield 1.00%
FCF Yield 0.37%
Dividend Details

Analyst Forecast

The average price target for BMRN is $108.28, which is 23.89% higher than the current price. The consensus rating is "Buy".

Price Target $108.28
Price Target Difference 23.89%
Analyst Consensus Buy
Analyst Count 19
Revenue Growth Forecast (5Y) 13.90%
EPS Growth Forecast (5Y) 52.19%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BMRN has an Altman Z-Score of 5.95 and a Piotroski F-Score of 6.

Altman Z-Score 5.95
Piotroski F-Score 6